PolarityTE, Inc., a biotechnology company developing and commercializing regenerative tissue products and biomaterials, announced that patient enrollment has begun for two new randomized controlled trials evaluating SkinTE™ for the treatment of chronic wounds, specifically diabetic foot ulcers and venous leg ulcers.
April 1, 2019
· 4 min read